Brain tumor revealed by treatment-resistant depression

December 22, 2015

A woman who was thought to have treatment-resistant depression was later found to have a tumour in her brain, according to an article published in BMJ Case Reports.

The 54-year-old woman had been depressed for 6 months, but treatment with the antidepressant fluoxetine and the anti-anxiety medication bromazepam was discontinued after 5 months because these were not found to be effective.

Her symptoms included apathy, difficulties with making decisions and initiating action, a lack of energy, sleep disorders, and concentration and attention problems.

She had suicidal thoughts, admitted self-accusation due to ineffectiveness in her job, and lost interest in her usual past times. She did not have a history of personal or familial mental illness, but experienced several .

A neurological examination was normal. However, a CT scan and MRI revealed meningiomatosis with a giant meningioma—the most common primary benign brain tumour—in her left frontal lobe.

This is an area known to have an important role in the development of depression for with tumours in the brain.

The patient underwent emergency surgery, and made a recovery. The disappeared within one month.

Psychiatric symptoms such as depression, mania, hallucinations, anxiety disorders and anorexia nervosa, even without any neurological signs, may be a sign of a brain tumour, write the doctors who treated the patient.

They say that certain patients should have a brain scan to identify or exclude the possibility of a tumour, but note that "it seems unrealistic to prescribe brain imaging in every patient with a depressive syndrome" because this mental disorder is common while are "remarkably rare" in patients with depression.

They recommend that it should be performed if the patient presents a late onset of depressive syndrome after 50 years of age, if a diagnosis of treatment-resistant depression is made or if the patient is apathetic.

Explore further: Certain antidepressants linked to heightened risk of mania and bipolar disorder

More information: Meningiomatosis revealed by a major depressive syndrome, BMJ Case Reports, casereports.bmj.com/content/2015/bcr-2015-211909

Related Stories

Certain antidepressants linked to heightened risk of mania and bipolar disorder

December 15, 2015
Taking certain antidepressants for depression is linked to a heightened risk of subsequent mania and bipolar disorder, reveals research published in the online journal BMJ Open.

Brain tumor patients should be screened for depression

April 29, 2015
Because depression in brain cancer patients is a common but often overlooked condition, oncologists should regularly screen tumor patients for depression, according to an article in the current issue of CNS Oncology.

Depression too often reduced to a checklist of symptoms

October 23, 2015
How can you tell if someone is depressed? The Diagnostic and Statistical Manual of Mental Disorders (DSM) - the 'bible' of psychiatry - diagnoses depression when patients tick off a certain number of symptoms on the DSM checklist. ...

First mouse model of spontaneous depression-like episodes shows new candidate brain region

October 20, 2015
Scientists from the RIKEN Brain Science Institute have shown that a mouse strain with a mutation that leads to dysfunction of mitochondria—the "powerhouses" that provide energy to cells—spontaneously undergo periodic ...

High-fat diet may cause changes in the brain that lead to anxiety and depression

October 19, 2015
A new study in mice reveals that increased body weight and high blood sugar as a result of consuming a high-fat diet may cause anxiety and depressive symptoms and measurable changes in the brain.

Scientists discover how to better map brain tumors

November 3, 2015
Scientists have discovered a protein that helps map the edge of brain tumours more clearly so they show up on magnetic resonance imaging (MRI) scans, according to new research presented at the National Cancer Research Institute ...

Recommended for you

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Testing the accuracy of FDA-approved and lab-developed cancer genetics tests

December 14, 2017
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.